Thymosin Alpha-1 (Tα1) vs LL-37
Thymosin Alpha-1 vs LL-37: immune modulator vs direct antimicrobial peptide. Different jobs in the same system.
The verdict
Same immune system, two different jobs. Thymosin Alpha-1 modulates and tunes the immune response, it's approved in many countries for hepatitis and used as a chemo adjunct, and people reach for it with chronic immune issues or slow post-illness recovery. LL-37 is a direct antimicrobial peptide your body already makes, aimed more at active infections and biofilm-associated problems. For broad immune support and regulation, Thymosin Alpha-1. For a targeted antimicrobial angle, LL-37. They solve different parts of the puzzle rather than competing.
Thymosin Alpha-1 is the immune-system peptide. Approved in many countries for hepatitis and as adjunct to chemotherapy. Used here for chronic immune issues, post-illness recovery, or as a winter immune-support tool.
LL-37 is an antimicrobial peptide your innate immune system already makes. People use it for chronic infections, biofilms (bacterial slime that resists antibiotics), and immune support. Strong effect in lab data, less data in humans.
Which one should you pick?
Pick Thymosin Alpha-1 (Tα1) if users with chronic immune issues or post-illness recovery support.
Pick LL-37 if users with chronic biofilm-associated infections or wound-healing contexts.
Still torn between Thymosin Alpha-1 (Tα1) and LL-37?
The AI Coach reads both, asks about your goal and experience, and tells you which one actually fits — plus how to dose and stack it. Free.